当代门诊关节置换术与住院手术相比安全性的倾向评分匹配分析
基于美国外科质量改进计划数据库2009至2018年574,375例初次髋、膝、单髁关节置换术,门诊手术占3.74%;经1:4倾向评分匹配后,门诊关节置换术30天不良事件率低于住院手术(3.18%比7.45%,P<0.001),且30天再入院率无差异。
要点
- 门诊关节置换术30天不良事件率显著低于匹配的住院手术(3.18%比7.45%,P<0.001)。
- 门诊全膝、全髋、单髁置换术不良事件率均低于住院对应术式,再入院率无差异。
- 门诊关节置换术是不良事件较低的独立因素(OR 0.407,95%CI 0.369-0.449,P<0.001),再入院风险未增加(OR 1.004,95%CI 0.878-1.148,P=0.951)。
核心结论
- 当代门诊关节置换术与风险匹配的住院手术相比,不良事件率更低且30天再入院率未增加。
研究设计与样本
- 回顾性队列研究,利用美国外科质量改进计划数据库2009至2018年数据,纳入574,375例初次全髋、全膝及单髁关节置换术患者,采用10个围手术期变量进行1:4倾向评分匹配,比较30天不良事件和再入院率。
主要发现
- 574,375例患者中21,506例(3.74%)接受门诊手术。
- 倾向评分匹配后,门诊关节置换术不良事件率为3.18%,住院手术为7.45%(p < 0.001)。
- 门诊全膝置换术不良事件率3.15%比8.11%(p < 0.001),全髋置换术4.94%比10.05%(p < 0.001),单髁置换术1.78%比3.39%(p < 0.001),再入院率均无差异。
- 门诊关节置换术是不良事件较低的独立因素(OR 0.407,95%CI 0.369-0.449,p < 0.001),再入院风险无增加(OR 1.004,95%CI 0.878-1.148,p = 0.951)。
关键数值与推荐
- 门诊关节置换术不良事件率3.18% vs 住院7.45%(p < 0.001);再入院率无差异。
- 门诊全膝置换术不良事件率3.15% vs 8.11%(p < 0.001)。
- 门诊全髋置换术不良事件率4.94% vs 10.05%(p < 0.001)。
- 门诊单髁置换术不良事件率1.78% vs 3.39%(p < 0.001)。
- 门诊关节置换术不良事件OR 0.407(95%CI 0.369-0.449,p < 0.001),再入院OR 1.004(95%CI 0.878-1.148,p = 0.951)。
临床怎么用
- 在风险匹配条件下,门诊关节置换术可作为住院关节置换术的安全替代方案,但需结合多因素综合决策。
局限性
- 证据等级为治疗性III级,为回顾性数据库分析,可能存在未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Outpatient joint arthroplasty is a potential modality for increased case throughput and is rising in demand. However, we are aware of no study that has compared outcomes between risk-matched outpatient and inpatient procedures within the last 7 years. The aims of this study were to compare matched patient cohorts who underwent outpatient or inpatient joint arthroplasty in terms of 30-day adverse events and readmission rates. METHODS: From the National Surgical Quality Improvement Program database, we identified patients who underwent primary total hip arthroplasty (THA), primary total knee arthroplasty (TKA), and primary unicompartmental knee arthroplasty (UKA) from 2009 to 2018. Using 10 perioperative variables, patients who underwent an outpatient procedure were 1:4 propensity score-matched with patients who underwent an inpatient procedure. The rates of 30-day adverse events and readmission were compared using the McNemar test. The risk factors for adverse events and readmissions were identified using multivariate regression. RESULTS: Of 574,375 patients identified, 21,506 (3.74%) underwent an outpatient procedure. After propensity score matching, an outpatient joint arthroplasty was associated with a lower rate of adverse events (3.18% compared with 7.45%; p < 0.001). When assessed individually, outpatient TKA (3.15% compared with 8.11%; p < 0.001), THA (4.94% compared with 10.05%; p < 0.001), and UKA (1.78% compared with 3.39%; p < 0.001) were all associated with fewer adverse events overall and there was no difference in the rate of 30-day readmission, when compared with inpatient analogs. Outpatient joint arthroplasty was an independent factor for lower adverse events (odds ratio [OR], 0.407 [95% confidence interval (CI), 0.369 to 0.449]; p < 0.001), with no increase in the risk of readmission (OR, 1.004 [95% CI, 0.878 to 1.148]; p = 0.951). CONCLUSIONS: Contemporary outpatient joint arthroplasty demonstrated lower rates of adverse events with no increased rate of 30-day readmission when compared with risk-matched inpatient counterparts. Although multiple factors should guide the decision for the site of care, outpatient arthroplasty may be a safe alternative to inpatient arthroplasty. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Lan RH, Samuel LT, Grits D, et al. Contemporary Outpatient Arthroplasty Is Safe Compared with Inpatient Surgery: A Propensity Score-Matched Analysis of 574,375 Procedures. J Bone Joint Surg Am. 2021. PMID: 33646984. doi:10.2106/JBJS.20.01307
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。